New implant could replace glaucoma drops after cataract surgery
NCT ID NCT06848946
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests a tiny implant placed inside the eye during cataract surgery that slowly releases travoprost, a drug that lowers eye pressure. About 132 adults with glaucoma or high eye pressure will receive either the implant plus surgery or surgery alone. The goal is to see if the implant safely controls eye pressure better than surgery alone.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
travoprost intracameral implant
What this could lead to
If it works, this could offer a way to control eye pressure for months after cataract surgery without daily eye drops.
What could go wrong
This is a phase 4 trial with only 132 participants, so results may not apply to everyone. The implant could cause inflammation or fail to lower pressure enough.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLAUCOMA, OPEN-ANGLE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Glaukos Investigator Site
RECRUITINGKenosha, Wisconsin, 53142, United States
Contact Email: •••••@•••••